You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • P275 Comparing clinically relevant improvement with umeclidinium/vilanterol and tiotropium/olodaterol in symptomatic copd: a randomised non-inferiority crossover trial

Article metrics

Article menu

Download PDFPDF

Pharmacotherapies for COPD
P275 Comparing clinically relevant improvement with umeclidinium/vilanterol and tiotropium/olodaterol in symptomatic copd: a randomised non-inferiority crossover trial
Free

 

Online download statistics by month:

Online download statistics by month: November 2017 to August 2024

AbstractFullPdf
Nov 20176808
Dec 20178409
Jan 20186003
Feb 20187805
Mar 20188006
Apr 20186204
May 20187204
Jun 20182803
Jul 20185204
Aug 20182003
Sep 20183002
Oct 20183205
Nov 20181806
Dec 20181801
Jan 20193605
Feb 20192304
Mar 20192607
Apr 20191201
May 201952016
Jun 20193407
Jul 20193104
Aug 20192204
Sep 2019801
Oct 20192408
Nov 20191306
Dec 20191302
Jan 20201000
Feb 2020605
Mar 2020402
Apr 2020104
May 2020901
Jun 2020604
Jul 2020800
Aug 20201003
Sep 2020706
Oct 20201504
Nov 2020402
Dec 20201304
Jan 2021603
Feb 2021302
Mar 20212602
May 2021003
Jun 2021001
Jul 2021106
Aug 2021002
Sep 2021005
Oct 20218020
Nov 20214014
Dec 2021601
Jan 2022801
Feb 20221404
Mar 20221000
Apr 2022800
May 202211010
Jun 2022702
Jul 2022600
Aug 20222504
Sep 20221109
Oct 20221202
Nov 20221006
Dec 2022600
Jan 20231401
Feb 20231801
Mar 20232000
Apr 2023603
May 2023400
Jun 20231400
Jul 20232202
Aug 2023202
Sep 20231600
Oct 20231003
Nov 2023903
Dec 2023600
Jan 20241401
Feb 2024401
Mar 20246053
Apr 20248012
May 2024702
Jun 20242001
Jul 2024602
Aug 2024800
Total14850347